secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syndax Pharmaceuticals Inc (SNDX)
CIK:        0001395937
Form:       8-K
Filed at:   2022-05-11T23:59:59+00:00
Accession:  0001564590-22-019515
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Syndax stockholders elect directors, approve say-on-pay, ratify auditor at 2022 annual meeting
--------------------------------------------------------------------------------

- All three director nominees elected: Katkin 27.7M for/16.4M withheld, Morrison 25.4M/18.7M, Podlesak 23.4M/20.7M.
- Advisory vote on executive compensation approved: 43.9M for, 227K against, 7.8K abstain.
- Stockholders recommended annual say-on-pay frequency (43.4M for 1 year); board adopted annual vote.
- Ratification of Deloitte & Touche as auditor: 49.2M for, 17K against, 759 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1395937/000156459022019515/0001564590-22-019515-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1395937/000156459022019515/sndx-8k_20220511.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-019515

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer